Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cytotherapy. 2018 Apr 11;20(5):728–739. doi: 10.1016/j.jcyt.2018.03.001

Figure 1. Comparison of HER2/neu expression by adHER2/neu DCs manufactured with autologous and AB plasma.

Figure 1

At least one HER2/neu DC was manufactured with autologous plasma and healthy donor AB plasma from 20 patients. The expression of HER2/neu for the first manufactured DC of each type, autologous plasma and AB plasma, is shown. Panels A and B show the same data with Panel B showing the relationship of expression by HER2/neu DCs for each patient. HER2/neu expression was assessed by flow cytometry using a CD340 antibody.